Zomig and Post procedural oedema - a phase IV clinical study of FDA data

Summary:

Post procedural oedema is reported as a side effect among people who take Zomig (zolmitriptan), especially for people who are female, 50-59 old, also take Mirena, and have Hyperandrogenism.

The phase IV clinical study analyzes which people have Post procedural oedema when taking Zomig. It is created by eHealthMe based on reports of 6,908 people who have side effects when taking Zomig from the FDA, and is updated regularly.

What is Zomig?

Zomig has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 7,356 Zomig users. Check the latest studies of Zomig.

What is Post procedural oedema?

Post procedural oedema (excessive build-up of fluid in the body's tissues after procedure) is found to be associated with 33 drugs and 101 conditions by eHealthMe. Check the latest studies of Post procedural oedema.

On Jul, 10, 2026

6,908 people reported to have side effects when taking Zomig.
Among them, 14 people (0.2%) have Post procedural oedema.

Could Zomig cause Post procedural oedema?

Among these 14 people:

What is the gender of people who have Post procedural oedema when taking Zomig? *

female: 100 %
male: 0.0 %

What is the age of people who have Post procedural oedema when taking Zomig? *

What are other drugs people take besides Zomig? *

Mirena: 14 people, 100.00%
Estradiol: 6 people, 42.86%
Botox: 5 people, 35.71%
Ketoprofen: 4 people, 28.57%
Estrogel: 4 people, 28.57%

What are other side effects people have besides Post procedural oedema? *

Muscle Tightness: 14 people, 100.00%
Headache (pain in head): 14 people, 100.00%
Speech Impairment (Adult) (inability to speak (adult)): 14 people, 100.00%
Facial Paralysis (loss of function of face muscle): 14 people, 100.00%
Fatigue (feeling of tiredness): 14 people, 100.00%
Meningioma (a diverse set of tumours arising from the meninges): 14 people, 100.00%
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions): 14 people, 100.00%
Nausea (feeling of having an urge to vomit): 13 people, 92.86%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 13 people, 92.86%
Motormental Retardation (a slowing-down of thought and a reduction of physical work): 9 people, 64.29%

What are the existing conditions these people have? *

Hyperandrogenism (androgen excess): 10 people, 71.43%
Excessive Or Unwanted Hair In Women: 5 people, 35.71%
Birth Control: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Zomig and have Post procedural oedema?

- Check whether Post procedural oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zomig:

Zomig (7,356 reports)

Browse all side effects of Zomig:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural oedema:

Post procedural oedema (33 drugs)

Browse all the conditions that are associated with Post procedural oedema:

Post procedural oedema (101 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zolmitriptan (the active ingredients of Zomig) and Zomig (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.